Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial

Autor: Joshi, Nikhil V, Vesey, Alex T, Williams, Michelle C, Shah, Anoop S V, Calvert, Patrick A, Craighead, Felicity H M, Yeoh, Su Ern, Wallace, William, Salter, Donald, Fletcher, Alison M, van Beek, Edwin J R, Flapan, Andrew D, Uren, Neal G, Behan, Miles W H, Cruden, Nicholas L M, Mills, Nicholas L, Fox, Keith A A, Rudd, James H F, Dweck, Marc R, Newby, David E

Publikováno v: In The Lancet 22-28 February 2014 383(9918):705-713

Relationship of Dapagliflozin With Serum Sodium:Findings From the DAPA-HF Trial

Autor: Yeoh, Su Ern, Docherty, Kieran F., Jhund, Pardeep S., Petrie, Mark C., Inzucchi, Silvio E., Køber, Lars, Kosiborod, Mikhail N., Martinez, Felipe A., Ponikowski, Piotr, Sabatine, Marc S., Bengtsson, Olof, Boulton, David W., Greasley, Peter J., Langkilde, Anna Maria, Sjöstrand, Mikaela, Solomon, Scott D., McMurray, John J. V.

Publikováno v: Yeoh, S E, Docherty, K F, Jhund, P S, Petrie, M C, Inzucchi, S E, Køber, L, Kosiborod, M N, Martinez, F A, Ponikowski, P, Sabatine, M S, Bengtsson, O, Boulton, D W, Greasley, P J, Langkilde, A M, Sjöstrand, M, Solomon, S D & McMurray, J J V 2022, ' Relationship of Dapagliflozin With Serum Sodium : Findings From the DAPA-HF Trial ', JACC: Heart Failure, vol. 10, no. 5, pp. 306-318 . https://doi.org/10.1016/j.jchf.2022.01.019

Objectives: This study aimed to assess the prognostic importance of hyponatremia and the effects of dapagliflozin on serum sodium in the DAPA-HF (Dapagliflozin And Prevention of Adverse outcomes in Heart Failure) trial. Background: Hyponatremia is co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2751::f2996ebaf0546fa19215bc002cee9b5a
https://curis.ku.dk/ws/files/344648287/1_s2.0_S221317792200169X_main.pdf

Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism

Autor: Robertson, Lindsay, Yeoh, Su Ern, Ramli, Ahmad

Background: Currently, little evidence is available on the length and type of anticoagulation used for extended treatment for prevention of recurrent venous thromboembolism (VTE) in patients with unprovoked VTE who have completed initial oral anticoa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::ad314e27224dbb7a0ff4e624d2054e4e
https://eprints.whiterose.ac.uk/145623/1/Robertson_et_al_2017_Cochrane_Database_of_Systematic_Reviews_4_.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.